{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:46Z","timestamp":1788401626367,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PROJ-01113"],"award-info":[{"award-number":["PROJ-01113"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127749","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T12:05:24Z","timestamp":1758024324000},"page":"127749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comparing the immunogenicity of intradermal and intramuscular vaccination of elderly with BNT162b2 XBB.1.5: An equivalent dose study"],"prefix":"10.1016","volume":"64","author":[{"given":"Lucille F.","family":"van Beek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije S.","family":"Koks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"van der Gaast-de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.E.","family":"Roukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo G.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Diavatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127749_bb0005","article-title":"Vaccines for older adults","volume":"372","author":"Cunningham","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.127749_bb0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/infdis\/jiab592","article-title":"Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults","volume":"225","author":"Brockman","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127749_bb0015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41564-022-01166-0","article-title":"COVID vaccination in older adults","volume":"7","author":"H\u00e4gg","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127749_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.571416","article-title":"Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections?","volume":"11","author":"Bajaj","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smim.2018.10.010","article-title":"Vaccination in the elderly: the challenge of immune changes with aging","volume":"40","author":"Ciabattini","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114175","article-title":"An old problem with new solutions: strategies to improve vaccine efficacy in the elderly","volume":"183","author":"Bell","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2025.127749_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2477300","article-title":"Age-related changes in the immune system and challenges for the development of age-specific vaccines","volume":"57","author":"Doherty","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.vaccine.2025.127749_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8303648","article-title":"Alternative methods of vaccine delivery: an overview of edible and intradermal vaccines","volume":"2019","author":"Criscuolo","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2025.127749_bb0050","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2015.05.012","article-title":"Recent insights into cutaneous immunization: how to vaccinate via the skin","volume":"33","author":"Engelke","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0055","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1586\/14760584.7.8.1201","article-title":"Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice","volume":"7","author":"Nicolas","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127749_bb0060","series-title":"Program for appropriate technology in health. Intradermal delivery of vaccines: a review of the literature and the potential for development for use in low- and middle-income countries","author":"WHO","year":"2009"},{"key":"10.1016\/j.vaccine.2025.127749_bb0065","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127749_bb0070","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1208\/s12249-022-02250-8","article-title":"Microneedle-based vaccine delivery: review of an emerging technology","volume":"23","author":"Mansoor","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vaccine.2025.127749_bb0080","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(22)00075-4","article-title":"COVID-19 vaccine dose sparing: strategies to improve vaccine equity and pandemic preparedness","volume":"10","author":"Roozen","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127749_bb0085","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2147\/RMHP.S309707","article-title":"Intradermal vaccination: a potential tool in the battle against the COVID-19 pandemic?","author":"Migliore","year":"2021","journal-title":"Risk Manage Healthcare Policy"},{"key":"10.1016\/j.vaccine.2025.127749_bb0090","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.7326\/M22-2089","article-title":"Safety and immunogenicity of intradermal fractional dose administration of the mRNA-1273 vaccine: a proof-of-concept study","volume":"175","author":"Roozen","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2025.127749_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00785-w","article-title":"Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial","volume":"9","author":"Prins","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2025.127749_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127330","article-title":"Low-dose intradermal mRNA-1273 boosting vaccine following BBiBP-CorV vaccination during the omicron pandemics","volume":"61","author":"Chaiwong","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0105","article-title":"Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine","volume":"X 12","author":"Temtanakitpaisan","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0110","article-title":"Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)","volume":"X 10","author":"Chalermphanchai","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1080791","article-title":"Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations","volume":"13","author":"Niyomnaitham","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0120","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3390\/vaccines10091494","article-title":"T-cell responses induced by an intradermal BNT162b2 mRNA vaccine booster following primary vaccination with inactivated SARS-CoV-2 vaccine","volume":"10","author":"Sophonmanee","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127749_bb0125","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.3390\/vaccines10091497","article-title":"Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: a pilot study","volume":"10","author":"Niyomnaitham","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127749_bb0130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/vaccines9121375","article-title":"Immunogenicity and safety of an intradermal BNT162b2 mRNA vaccine booster after two doses of inactivated SARS-CoV-2 vaccine in healthy population","volume":"9","author":"Intapiboon","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127749_bb0135","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/infdis\/jiad133","article-title":"Immunogenicity and reactogenicity of messenger RNA coronavirus disease 2019 vaccine booster administered by intradermal or intramuscular route in Thai older adults","volume":"228","author":"Assantachai","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127749_bb0140","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/s41467-021-25949-x","article-title":"SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms","volume":"12","author":"Fr\u00f6berg","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127749_bb0145","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.127749_bb0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/infdis\/jiad385","article-title":"Primary exposure to SARS-CoV-2 via infection or vaccination determines mucosal antibody-dependent ACE2 binding inhibition","volume":"229","author":"Fr\u00f6berg","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127749_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2025.127749_bb0160","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2025.127749_bb0165","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.immuni.2008.05.012","article-title":"A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus","volume":"29","author":"Chaussabel","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.127749_bb0180","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1093\/bioinformatics\/btz447","article-title":"Gene set enrichment for reproducible science: comparison of CERNO and eight other algorithms","volume":"35","author":"Zyla","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2025.127749_bb0185","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.vaccine.2015.01.072","article-title":"Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials","volume":"33","author":"Donken","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm9183","article-title":"Vaccination for healthy aging","volume":"16","author":"Bloom","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127749_bb0195","article-title":"Immunogenicity and reactogenicity of repeated intradermal mRNA COVID-19 vaccines administered as a second booster dose in a Thai geriatric population","volume":"14","author":"Assantachai","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127749_bb0200","article-title":"Immunogenicity of intradermal versus intramuscular BNT162b2 COVID-19 booster vaccine in patients with immune-mediated dermatologic diseases: a non-inferiority randomized controlled trial","volume":"12","author":"Seree-Aphinan","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127749_bb0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.127749_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110680","article-title":"mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron","volume":"39","author":"Lee","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2025.127749_bb0215","article-title":"A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines","volume":"4","author":"Ryan","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.vaccine.2025.127749_bb0220","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.127749_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2024.03.028","article-title":"Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose","author":"Roozen","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.127749_bb0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000213172","article-title":"Skin thickness changes in normal aging skin","volume":"36","author":"Branchet","year":"1990","journal-title":"Gerontology"},{"key":"10.1016\/j.vaccine.2025.127749_bb0235","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.vaccine.2023.02.040","article-title":"The immunological effects of intradermal particle-based vaccine delivery using a novel microinjection needle studied in a human skin explant model","volume":"41","author":"Beaujean","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127749_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.02.016","article-title":"Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans","volume":"57","author":"Tortorici","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.127749_bb0245","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1038\/s41598-024-57931-0","article-title":"Factors impacting antibody kinetics, including fever and vaccination intervals, in SARS-CoV-2-na\u00efve adults receiving the first four mRNA COVID-19 vaccine doses","volume":"14","author":"Matsuura","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127749_bb0250","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S1473-3099(23)00690-4","article-title":"Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination","volume":"24","author":"Stankov","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127749_bb0255","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp8920","article-title":"SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity","volume":"16","author":"Lasrado","year":"2024","journal-title":"Sci Transl Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:22:23Z","timestamp":1777537343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S0264410X25010461"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127749","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the immunogenicity of intradermal and intramuscular vaccination of elderly with BNT162b2 XBB.1.5: An equivalent dose study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127749"}}